Literature DB >> 18989165

Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.

Nataly Apollonsky1, Ashok Shende, Ihsane Ouansafi, Judith Brody, Mark Atlas, Banu Aygun.   

Abstract

Transient myeloproliferative disorder (TMD) in newborns with Down syndrome (DS) has been well described. We report 4 newborns, 2 with DS and 2 without DS, who developed TMD. One newborn with DS developed multiorgan failure and died despite treatment with low-dose cytarabine. In 3 newborns, the TMD resolved spontaneously. Two of these patients, 1 with and 1 without DS developed leukemia on subsequent follow-up and were treated successfully. We reviewed the clinical and laboratory data on 14 non-DS infants with TMD reported in the literature. According to limited data, these patients are more likely to develop leukemia than DS patients, however their outcome is better.

Entities:  

Mesh:

Year:  2008        PMID: 18989165     DOI: 10.1097/MPH.0b013e31818a953e

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  8 in total

1.  Transient abnormal myelopoiesis in a cytogenetically normal neonate.

Authors:  Kentaro Yanase; Keisuke Kato; Nobuko Katayama; Yoko Mouri; Chie Kobayashi; Junko Shiono; Masakazu Abe; Ai Yoshimi; Kazutoshi Koike; Jun-Ichi Arai; Masahiro Tsuchida
Journal:  Int J Hematol       Date:  2010-09-23       Impact factor: 2.490

2.  Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.

Authors:  Hiroto Inaba; Margherita Londero; Scott H Maurer; Mihaela Onciu; Yubin Ge; Jeffrey W Taub; Jeffrey E Rubnitz; Susana C Raimondi
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

3.  Hyperleukocytosis in a neonate: A diagnostic dilemma.

Authors:  K Shreedhara Avabratha; Kiran Joseph Tauro; G K Shwethadri
Journal:  Indian J Med Paediatr Oncol       Date:  2010-07

4.  Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report.

Authors:  Athanasios Tragiannidis; Zoe Dorothea Pana; Theodotis Papageorgiou; Emmanuel Hatzipantelis; Maria Hatzistilianou; Fani Athanassiadou
Journal:  J Med Case Rep       Date:  2011-08-24

5.  Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21.

Authors:  Francesco Corazza; Annalisa Astolfi; Virginia Libri; Monica Franzoni; Salvatore Serravalle; Rosina Alessandroni; Fraia Melchionda; Andrea Pession
Journal:  Int J Hematol       Date:  2014-04-26       Impact factor: 2.319

6.  Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis.

Authors:  Guglielmo Salvatori; Silvia Foligno; Pietro Sirleto; Silvia Genovese; Serena Russo; Valentina Coletti; Andrea Dotta; Matteo Luciani
Journal:  Oncol Lett       Date:  2016-11-21       Impact factor: 2.967

Review 7.  Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.

Authors:  Anouchka P Laurent; Rishi S Kotecha; Sébastien Malinge
Journal:  Leukemia       Date:  2020-05-20       Impact factor: 11.528

Review 8.  Advances in molecular characterization of myeloid proliferations associated with Down syndrome.

Authors:  Jixia Li; Maggie L Kalev-Zylinska
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.